Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Massachusetts General Hospital
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female 18-60 years of age
Candidate for a living-donor renal allograft with a one haplotype identical donor identified.
First or second transplant with either a living donor or cadaveric transplant as the first transplant.
Positive serologic testing for EBV indicating past exposure.
You may not be if
ABO blood group-incompatible renal allograft.
Evidence of anti-HLA antibody within 60 days prior to transplant as assessed by routine methodology (AHG and/or ELISA)
Positive testing for: HIV, hepatitis B core antigen, or hepatitis C virus or positivity for hepatitis B surface antigen.
Cardiac ejection fraction \< 40% or clinical evidence of insufficiency.
History of cancer other than basal cell carcinoma of the skin or carcinoma in situ of the cervix.
Underlying renal disease etiology with a high risk of disease recurrence in the transplanted kidney (such as focal segmental glomerulosclerosis, type I or II nonproliferative glomerulonephritis).
Prior dose-limiting radiation therapy.
Abnormal (\>2 times lab normal) values for (a) liver function chemistries (ALT, AST, AP), (b) bilirubin, (c) coagulation studies (PT, PTT).
The presence of any medical condition that the investigator deems incompatible with participation in the trial.